Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174406 · ClinicalTrials.gov registry record
Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,494
- Enrollment target
NCT02174406: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02174406 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,494 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174406 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,494 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and DBT.
Primary Outcome
The detection rate of each imaging test is defined as the proportion of patients who are positive on that imaging test who truly have the disease compared to the total number of women screened. A positive imaging test is defined as a test with a recommendation for biopsy (BI-RADS 4 or 5).
Interventions
- PROCEDURE breast ultrasound
- PROCEDURE DBT (Full field digital mammography + tomosynthesis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,494 participants |
| Start Date | 2014-06-23 |
| Est. Completion | 2023-01-19 |
What the finished NCT02174406 record still lists
NCT02174406 is an observational study that tracks outcomes without assigning an intervention. Its 1,494 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which breast ultrasound is the first listed.
NCT02174406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02174406 about?
NCT02174406 is a clinical study titled "Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis". The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and DBT.
What is the current status of trial NCT02174406?
This trial is currently completed. The enrollment target is 1,494 participants. The study started on 2014-06-23. Estimated completion is 2023-01-19.
What interventions are being tested in trial NCT02174406?
The interventions under investigation include: breast ultrasound (PROCEDURE), DBT (Full field digital mammography + tomosynthesis) (PROCEDURE).
Who is sponsoring clinical trial NCT02174406?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI